RSCM
Rock Springs Capital Management’s Applied Therapeutics APLT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Buy |
2,075,991
+1,100
| +0.1% | +$342 | 0.04% | 85 |
|
|
2025
Q1 | $1.01M | Buy |
2,074,891
+157,700
| +8% | +$77.1K | 0.06% | 88 |
|
|
2024
Q4 | $1.64M | Buy |
1,917,191
+170,742
| +10% | +$146K | 0.06% | 93 |
|
|
2024
Q3 | $14.8M | Buy |
1,746,449
+191,445
| +12% | +$1.63M | 0.48% | 56 |
|
|
2024
Q2 | $7.26M | Buy |
1,555,004
+57,086
| +4% | +$267K | 0.22% | 76 |
|
|
2024
Q1 | $10.2M | Buy |
1,497,918
+602,723
| +67% | +$4.1M | 0.26% | 78 |
|
|
2023
Q4 | $3M | Buy |
895,195
+86,386
| +11% | +$289K | 0.07% | 89 |
|
|
2023
Q3 | $2.01M | Buy |
808,809
+28,018
| +4% | +$69.8K | 0.05% | 100 |
|
|
2023
Q2 | $999K | Hold |
780,791
| – | – | 0.02% | 115 |
|
|
2023
Q1 | $633K | Buy |
780,791
+184,111
| +31% | +$149K | 0.02% | 116 |
|
|
2022
Q4 | $453K | Sell |
596,680
-105,000
| -15% | -$79.8K | 0.01% | 118 |
|
|
2022
Q3 | $653K | Hold |
701,680
| – | – | 0.02% | 124 |
|
|
2022
Q2 | $665K | Hold |
701,680
| – | – | 0.02% | 128 |
|
|
2022
Q1 | $1.48M | Hold |
701,680
| – | – | 0.04% | 127 |
|
|
2021
Q4 | $6.28M | Hold |
701,680
| – | – | 0.15% | 111 |
|
|
2021
Q3 | $11.6M | Hold |
701,680
| – | – | 0.24% | 101 |
|
|
2021
Q2 | $14.6M | Hold |
701,680
| – | – | 0.29% | 93 |
|
|
2021
Q1 | $13.2M | Buy |
701,680
+65,843
| +10% | +$1.23M | 0.29% | 93 |
|
|
2020
Q4 | $14M | Sell |
635,837
-355,736
| -36% | -$7.83M | 0.3% | 96 |
|
|
2020
Q3 | $20.6M | Hold |
991,573
| – | – | 0.52% | 62 |
|
|
2020
Q2 | $35.8M | Buy |
991,573
+145,873
| +17% | +$5.27M | 0.98% | 41 |
|
|
2020
Q1 | $27.6M | Buy |
845,700
+825,385
| +4,063% | +$27M | 1.14% | 34 |
|
|
2019
Q4 | $554K | Buy |
+20,315
| New | +$554K | 0.02% | 128 |
|